90 related articles for article (PubMed ID: 28633979)
1. Zerumbone modulates CD1d expression and lipid antigen presentation pathway in breast cancer cells.
Shyanti RK; Sehrawat A; Singh SV; Mishra JPN; Singh RP
Toxicol In Vitro; 2017 Oct; 44():74-84. PubMed ID: 28633979
[TBL] [Abstract][Full Text] [Related]
2. Zerumbone causes Bax- and Bak-mediated apoptosis in human breast cancer cells and inhibits orthotopic xenograft growth in vivo.
Sehrawat A; Arlotti JA; Murakami A; Singh SV
Breast Cancer Res Treat; 2012 Nov; 136(2):429-41. PubMed ID: 23053663
[TBL] [Abstract][Full Text] [Related]
3. Zerumbone Induces Apoptosis in Breast Cancer Cells by Targeting αvβ3 Integrin upon Co-Administration with TP5-iRGD Peptide.
E M Eid E; S Alanazi A; Koosha S; A Alrasheedy A; Azam F; M Taban I; Khalilullah H; Sadiq Al-Qubaisi M; A Alshawsh M
Molecules; 2019 Jul; 24(14):. PubMed ID: 31337024
[TBL] [Abstract][Full Text] [Related]
4. Zerumbone, a bioactive sesquiterpene, induces G2/M cell cycle arrest and apoptosis in leukemia cells via a Fas- and mitochondria-mediated pathway.
Xian M; Ito K; Nakazato T; Shimizu T; Chen CK; Yamato K; Murakami A; Ohigashi H; Ikeda Y; Kizaki M
Cancer Sci; 2007 Jan; 98(1):118-26. PubMed ID: 17129359
[TBL] [Abstract][Full Text] [Related]
5. Zerumbone, a Sesquiterpene, Controls Proliferation and Induces Cell Cycle Arrest in Human Laryngeal Carcinoma Cell Line Hep-2.
Jegannathan SD; Arul S; Dayalan H
Nutr Cancer; 2016 Jul; 68(5):865-72. PubMed ID: 27045964
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase inhibitors enhance CD1d-dependent NKT cell responses to lymphoma.
Tiper IV; Webb TJ
Cancer Immunol Immunother; 2016 Nov; 65(11):1411-1421. PubMed ID: 27614429
[TBL] [Abstract][Full Text] [Related]
7. CD1d-expressing breast cancer cells modulate NKT cell-mediated antitumor immunity in a murine model of breast cancer metastasis.
Hix LM; Shi YH; Brutkiewicz RR; Stein PL; Wang CR; Zhang M
PLoS One; 2011; 6(6):e20702. PubMed ID: 21695190
[TBL] [Abstract][Full Text] [Related]
8. Zerumbone induces apoptosis in T-acute lymphoblastic leukemia cells.
Abdelwahab SI; Abdul AB; Mohan S; Taha MM; Syam S; Ibrahim MY; Mariod AA
Leuk Res; 2011 Feb; 35(2):268-71. PubMed ID: 20708800
[TBL] [Abstract][Full Text] [Related]
9. STAT3 promotes CD1d-mediated lipid antigen presentation by regulating a critical gene in glycosphingolipid biosynthesis.
Iyer AK; Liu J; Gallo RM; Kaplan MH; Brutkiewicz RR
Immunology; 2015 Nov; 146(3):444-55. PubMed ID: 26260288
[TBL] [Abstract][Full Text] [Related]
10. Thymosin alpha1 enhanced cytotoxicity of iNKT cells against colon cancer via upregulating CD1d expression.
Ni C; Wu P; Wu X; Zhang T; Zhang T; Wang Z; Zhang S; Qiu F; Huang J
Cancer Lett; 2015 Jan; 356(2 Pt B):579-88. PubMed ID: 25304368
[TBL] [Abstract][Full Text] [Related]
11. Zerumbone suppresses the motility and tumorigenecity of triple negative breast cancer cells via the inhibition of TGF-β1 signaling pathway.
Kim S; Lee J; Jeon M; Lee JE; Nam SJ
Oncotarget; 2016 Jan; 7(2):1544-58. PubMed ID: 26637807
[TBL] [Abstract][Full Text] [Related]
12. Retinoic acid induction of CD1d expression primes chronic lymphocytic leukemia B cells for killing by CD8
Ghnewa YG; O'Reilly VP; Vandenberghe E; Browne PV; McElligott AM; Doherty DG
Clin Immunol; 2017 Oct; 183():91-98. PubMed ID: 28780376
[TBL] [Abstract][Full Text] [Related]
13. Lipid antigen presentation through CD1d pathway in mouse lung epithelial cells, macrophages and dendritic cells and its suppression by poly-dispersed single-walled carbon nanotubes.
Rizvi ZA; Puri N; Saxena RK
Toxicol In Vitro; 2015 Sep; 29(6):1275-82. PubMed ID: 25448806
[TBL] [Abstract][Full Text] [Related]
14. Zerumbone Sensitizes the Anti-Cancer Efficacy of Cisplatin in Hepatocellular Carcinoma Cells.
Jegannathan SD; Arul S; Dayalan H
Anticancer Agents Med Chem; 2022 Aug; 22(16):2885-2895. PubMed ID: 35331096
[TBL] [Abstract][Full Text] [Related]
15. Retinoic acid regulates CD1d gene expression at the transcriptional level in human and rodent monocytic cells.
Chen Q; Ross AC
Exp Biol Med (Maywood); 2007 Apr; 232(4):488-94. PubMed ID: 17392484
[TBL] [Abstract][Full Text] [Related]
16. Regulation of multiple myeloma survival and progression by CD1d.
Spanoudakis E; Hu M; Naresh K; Terpos E; Melo V; Reid A; Kotsianidis I; Abdalla S; Rahemtulla A; Karadimitris A
Blood; 2009 Mar; 113(11):2498-507. PubMed ID: 19056691
[TBL] [Abstract][Full Text] [Related]
17. Antileukemic effect of zerumbone-loaded nanostructured lipid carrier in WEHI-3B cell-induced murine leukemia model.
Rahman HS; Rasedee A; How CW; Zeenathul NA; Chartrand MS; Yeap SK; Abdul AB; Tan SW; Othman HH; Ajdari Z; Namvar F; Arulselvan P; Fakurazi S; Mehrbod P; Daneshvar N; Begum H
Int J Nanomedicine; 2015; 10():1649-66. PubMed ID: 25767386
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of CD1d-mediated antigen presentation by the transforming growth factor-β/Smad signalling pathway.
Bailey JC; Iyer AK; Renukaradhya GJ; Lin Y; Nguyen H; Brutkiewicz RR
Immunology; 2014 Dec; 143(4):679-91. PubMed ID: 24990409
[TBL] [Abstract][Full Text] [Related]
19. Zerumbone suppresses EGF-induced CD44 expression through the inhibition of STAT3 in breast cancer cells.
Kim S; Kil WH; Lee J; Oh SJ; Han J; Jeon M; Jung T; Lee SK; Bae SY; Lee HC; Lee JH; Yi HW; Kim SW; Nam SJ; Lee JE
Oncol Rep; 2014 Dec; 32(6):2666-72. PubMed ID: 25269647
[TBL] [Abstract][Full Text] [Related]
20. Notch2 activation is protective against anticancer effects of zerumbone in human breast cancer cells.
Sehrawat A; Sakao K; Singh SV
Breast Cancer Res Treat; 2014 Aug; 146(3):543-55. PubMed ID: 25038880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
